{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:22:53Z","timestamp":1794540173971,"version":"4.9.1"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biomark Res"],"DOI":"10.1186\/s40364-026-00952-w","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T11:38:29Z","timestamp":1781091509000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Circadian rhythm-guided cellular therapy in hematologic malignancies: mechanisms, clinical evidence, and optimization strategies"],"prefix":"10.1186","volume":"14","author":[{"given":"Yao","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiguo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"1","key":"952_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41408-023-00853-3","volume":"13","author":"N Zhang","year":"2023","unstructured":"Zhang N, Wu J, Wang Q, Liang Y, Li X, Chen G, et al. Global burden of hematologic malignancies and evolution patterns over the past 30 years. Blood Cancer J. 2023;13(1):82.","journal-title":"Blood Cancer J"},{"issue":"3","key":"952_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"22","key":"952_CR3","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2024.19462","volume":"332","author":"JN Brudno","year":"2024","unstructured":"Brudno JN, Maus MV, Hinrichs CS. CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review. JAMA. 2024;332(22):1924\u201335.","journal-title":"JAMA"},{"issue":"4","key":"952_CR4","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1001\/jamaoncol.2022.7605","volume":"9","author":"M Bornh\u00e4user","year":"2023","unstructured":"Bornh\u00e4user M, Schliemann C, Schetelig J, R\u00f6llig C, Kramer M, Glass B, et al. Allogeneic Hematopoietic Cell Transplantation vs Standard Consolidation Chemotherapy in Patients With Intermediate-Risk Acute Myeloid Leukemia: A Randomized Clinical Trial. JAMA Oncol. 2023;9(4):519\u201326.","journal-title":"JAMA Oncol"},{"issue":"16","key":"952_CR5","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1001\/jama.2010.491","volume":"303","author":"A Gratwohl","year":"2010","unstructured":"Gratwohl A, Baldomero H, Aljurf M, Pasquini MC, Bouzas LF, Yoshimi A, et al. Hematopoietic stem cell transplantation: a global perspective. JAMA. 2010;303(16):1617\u201324.","journal-title":"JAMA"},{"issue":"5","key":"952_CR6","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1016\/j.ymthe.2025.03.005","volume":"33","author":"KK Patel","year":"2025","unstructured":"Patel KK, Tariveranmoshabad M, Kadu S, Shobaki N, June C. From concept to cure: The evolution of CAR-T cell therapy. Mol Ther. 2025;33(5):2123\u201340.","journal-title":"Mol Ther"},{"issue":"12","key":"952_CR7","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/s41591-018-0271-8","volume":"24","author":"S Masri","year":"2018","unstructured":"Masri S, Sassone-Corsi P. The emerging link between cancer, metabolism, and circadian rhythms. Nat Med. 2018;24(12):1795\u2013803.","journal-title":"Nat Med"},{"key":"952_CR8","doi-asserted-by":"publisher","first-page":"105451","DOI":"10.1016\/j.ebiom.2024.105451","volume":"110","author":"M Motiei","year":"2024","unstructured":"Motiei M, Abu-Dawud R, Rel\u00f3gio A, Assaf C. Circadian rhythms in haematological malignancies: therapeutic potential and personalised interventions. EBioMedicine. 2024;110:105451.","journal-title":"EBioMedicine"},{"issue":"D1","key":"952_CR9","doi-asserted-by":"publisher","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","volume":"53","author":"S Jiang","year":"2025","unstructured":"Jiang S, Li H, Zhang L, Mu W, Zhang Y, Chen T, et al. Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics. Nucleic Acids Res. 2025;53(D1):D1670\u20136.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"952_CR10","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/0031-9384(94)90392-1","volume":"55","author":"WS Warren","year":"1994","unstructured":"Warren WS, Champney TH, Cassone VM. The suprachiasmatic nucleus controls the circadian rhythm of heart rate via the sympathetic nervous system. Physiol Behav. 1994;55(6):1091\u20139.","journal-title":"Physiol Behav"},{"key":"952_CR11","doi-asserted-by":"crossref","unstructured":"Zha K, Mi B, Xiong Y, Wu S, Lu L, Zhang S, et al. Circadian rhythm: biological functions, diseases, and therapeutic targets. MedComm (2020). 2025;6(11):e70435.","DOI":"10.1002\/mco2.70435"},{"key":"952_CR12","doi-asserted-by":"publisher","first-page":"103516","DOI":"10.1016\/j.jaut.2025.103516","volume":"158","author":"T Tian","year":"2026","unstructured":"Tian T, Rao L, Wei M, Du J, Gu Y, Wu X, et al. Circadian clock genes: Potential therapeutic targets for autoimmune diseases. J Autoimmun. 2026;158:103516.","journal-title":"J Autoimmun"},{"issue":"2","key":"952_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41580-019-0179-2","volume":"21","author":"A Patke","year":"2020","unstructured":"Patke A, Young MW, Axelrod S. Molecular mechanisms and physiological importance of circadian rhythms. Nat Rev Mol Cell Biol. 2020;21(2):67\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"952_CR14","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nrg.2016.150","volume":"18","author":"JS Takahashi","year":"2017","unstructured":"Takahashi JS. Transcriptional architecture of the mammalian circadian clock. Nat Rev Genet. 2017;18(3):164\u201379.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"952_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0092-8674(00)81014-4","volume":"98","author":"K Kume","year":"1999","unstructured":"Kume K, Zylka MJ, Sriram S, Shearman LP, Weaver DR, Jin X, et al. mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell. 1999;98(2):193\u2013205.","journal-title":"Cell"},{"issue":"14","key":"952_CR16","doi-asserted-by":"publisher","first-page":"R538","DOI":"10.1016\/j.cub.2007.05.067","volume":"17","author":"JP DeBruyne","year":"2007","unstructured":"DeBruyne JP, Weaver DR, Reppert SM. Peripheral circadian oscillators require CLOCK. Curr Biol. 2007;17(14):R538\u20139.","journal-title":"Curr Biol"},{"issue":"4","key":"952_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/MOH.0b013e32832bd0f5","volume":"16","author":"S M\u00e9ndez-Ferrer","year":"2009","unstructured":"M\u00e9ndez-Ferrer S, Chow A, Merad M, Frenette PS. Circadian rhythms influence hematopoietic stem cells. Curr Opin Hematol. 2009;16(4):235\u201342.","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"952_CR18","doi-asserted-by":"publisher","first-page":"e198780","DOI":"10.1172\/JCI198780","volume":"136","author":"RM Mello","year":"2026","unstructured":"Mello RM, Masri S, Lamia KA. Rhythms of risk: the intersection of clocks, cancer, and chronotherapy. J Clin Invest. 2026;136(3):e198780.","journal-title":"J Clin Invest"},{"issue":"7186","key":"952_CR19","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1038\/nature06685","volume":"452","author":"S M\u00e9ndez-Ferrer","year":"2008","unstructured":"M\u00e9ndez-Ferrer S, Lucas D, Battista M, Frenette PS. Haematopoietic stem cell release is regulated by circadian oscillations. Nature. 2008;452(7186):442\u20137.","journal-title":"Nature"},{"issue":"4","key":"952_CR20","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.stem.2018.08.002","volume":"23","author":"K Golan","year":"2018","unstructured":"Golan K, Kumari A, Kollet O, Khatib-Massalha E, Subramaniam MD, Ferreira ZS, et al. Daily Onset of Light and Darkness Differentially Controls Hematopoietic Stem Cell Differentiation and Maintenance. Cell Stem Cell. 2018;23(4):572\u2013e857.","journal-title":"Cell Stem Cell"},{"issue":"2","key":"952_CR21","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.cell.2005.10.041","volume":"124","author":"Y Katayama","year":"2006","unstructured":"Katayama Y, Battista M, Kao WM, Hidalgo A, Peired AJ, Thomas SA, et al. Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell. 2006;124(2):407\u201321.","journal-title":"Cell"},{"issue":"5","key":"952_CR22","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s12015-018-9836-7","volume":"14","author":"M Budkowska","year":"2018","unstructured":"Budkowska M, Ostrycharz E, Wojtowicz A, Marcinowska Z, Wo\u017aniak J, Ratajczak MZ, et al. A Circadian Rhythm in both Complement Cascade (ComC) Activation and Sphingosine-1-Phosphate (S1P) Levels in Human Peripheral Blood Supports a Role for the ComC-S1P Axis in Circadian Changes in the Number of Stem Cells Circulating in Peripheral Blood. Stem Cell Rev Rep. 2018;14(5):677\u201385.","journal-title":"Stem Cell Rev Rep"},{"issue":"4","key":"952_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.stem.2008.09.004","volume":"3","author":"D Lucas","year":"2008","unstructured":"Lucas D, Battista M, Shi PA, Isola L, Frenette PS. Mobilized hematopoietic stem cell yield depends on species-specific circadian timing. Cell Stem Cell. 2008;3(4):364\u20136.","journal-title":"Cell Stem Cell"},{"issue":"12","key":"952_CR24","doi-asserted-by":"publisher","first-page":"6291","DOI":"10.4049\/jimmunol.1004030","volume":"187","author":"EE Fortier","year":"2011","unstructured":"Fortier EE, Rooney J, Dardente H, Hardy MP, Labrecque N, Cermakian N. Circadian variation of the response of T cells to antigen. J Immunol. 2011;187(12):6291\u2013300.","journal-title":"J Immunol"},{"issue":"9","key":"952_CR25","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.celrep.2015.04.058","volume":"11","author":"S Hemmers","year":"2015","unstructured":"Hemmers S, Rudensky AY. The Cell-Intrinsic Circadian Clock Is Dispensable for Lymphocyte Differentiation and Function. Cell Rep. 2015;11(9):1339\u201349.","journal-title":"Cell Rep"},{"issue":"40","key":"952_CR26","doi-asserted-by":"publisher","first-page":"20077","DOI":"10.1073\/pnas.1905080116","volume":"116","author":"CC Nobis","year":"2019","unstructured":"Nobis CC, Dubeau Laram\u00e9e G, Kervezee L, Maurice De Sousa D, Labrecque N, Cermakian N. The circadian clock of CD8 T cells modulates their early response to vaccination and the rhythmicity of related signaling pathways. Proc Natl Acad Sci U S A. 2019;116(40):20077\u201386.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"952_CR27","doi-asserted-by":"publisher","first-page":"e29801","DOI":"10.1371\/journal.pone.0029801","volume":"6","author":"T Bollinger","year":"2011","unstructured":"Bollinger T, Leutz A, Leliavski A, Skrum L, Kovac J, Bonacina L, et al. Circadian clocks in mouse and human CD4\u2009+\u2009T cells. PLoS ONE. 2011;6(12):e29801.","journal-title":"PLoS ONE"},{"issue":"5","key":"952_CR28","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1111\/cas.14362","volume":"111","author":"G Yang","year":"2020","unstructured":"Yang G, Yang Y, Tang H, Yang K. Loss of the clock gene Per1 promotes oral squamous cell carcinoma progression via the AKT\/mTOR pathway. Cancer Sci. 2020;111(5):1542\u201354.","journal-title":"Cancer Sci"},{"issue":"4","key":"952_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/imm.13448","volume":"165","author":"CM Capelle","year":"2022","unstructured":"Capelle CM, Chen A, Zeng N, Baron A, Grzyb K, Arns T, et al. Stress hormone signalling inhibits Th1 polarization in a CD4 T-cell-intrinsic manner via mTORC1 and the circadian gene PER1. Immunology. 2022;165(4):428\u201344.","journal-title":"Immunology"},{"issue":"6159","key":"952_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1126\/science.1243884","volume":"342","author":"X Yu","year":"2013","unstructured":"Yu X, Rollins D, Ruhn KA, Stubblefield JJ, Green CB, Kashiwada M, et al. TH17 cell differentiation is regulated by the circadian clock. Science. 2013;342(6159):727\u201330.","journal-title":"Science"},{"issue":"1","key":"952_CR31","first-page":"15","volume":"53","author":"JL Chang","year":"2022","unstructured":"Chang JL, Qiu J. [Regulation of ILC3\/Th17-Mediated Intestinal Immune Response by Circadian Rhythm]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2022;53(1):15\u20139.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"issue":"1","key":"952_CR32","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.immuni.2016.12.011","volume":"46","author":"D Druzd","year":"2017","unstructured":"Druzd D, Matveeva O, Ince L, Harrison U, He W, Schmal C, et al. Lymphocyte Circadian Clocks Control Lymph Node Trafficking and Adaptive Immune Responses. Immunity. 2017;46(1):120\u201332.","journal-title":"Immunity"},{"issue":"21","key":"952_CR33","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1182\/blood-2008-11-190769","volume":"113","author":"S Dimitrov","year":"2009","unstructured":"Dimitrov S, Benedict C, Heutling D, Westermann J, Born J, Lange T. Cortisol and epinephrine control opposing circadian rhythms in T cell subsets. Blood. 2009;113(21):5134\u201343.","journal-title":"Blood"},{"issue":"4","key":"952_CR34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1365-2567.2006.02456.x","volume":"119","author":"Y Sun","year":"2006","unstructured":"Sun Y, Yang Z, Niu Z, Peng J, Li Q, Xiong W, et al. MOP3, a component of the molecular clock, regulates the development of B cells. Immunology. 2006;119(4):451\u201360.","journal-title":"Immunology"},{"issue":"3","key":"952_CR35","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1073\/pnas.1915932117","volume":"117","author":"GB Kitchen","year":"2020","unstructured":"Kitchen GB, Cunningham PS, Poolman TM, Iqbal M, Maidstone R, Baxter M, et al. The clock gene Bmal1 inhibits macrophage motility, phagocytosis, and impairs defense against pneumonia. Proc Natl Acad Sci U S A. 2020;117(3):1543\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"952_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1248\/bpb.30.621","volume":"30","author":"M Hayashi","year":"2007","unstructured":"Hayashi M, Shimba S, Tezuka M. Characterization of the molecular clock in mouse peritoneal macrophages. Biol Pharm Bull. 2007;30(4):621\u20136.","journal-title":"Biol Pharm Bull"},{"issue":"36","key":"952_CR37","doi-asserted-by":"publisher","first-page":"E8460","DOI":"10.1073\/pnas.1800431115","volume":"115","author":"JO Early","year":"2018","unstructured":"Early JO, Menon D, Wyse CA, Cervantes-Silva MP, Zaslona Z, Carroll RG, et al. Circadian clock protein BMAL1 regulates IL-1\u03b2 in macrophages via NRF2. Proc Natl Acad Sci U S A. 2018;115(36):E8460\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"952_CR38","doi-asserted-by":"publisher","first-page":"7086","DOI":"10.1038\/s41598-017-07100-3","volume":"7","author":"Y Oishi","year":"2017","unstructured":"Oishi Y, Hayashi S, Isagawa T, Oshima M, Iwama A, Shimba S, et al. Bmal1 regulates inflammatory responses in macrophages by modulating enhancer RNA transcription. Sci Rep. 2017;7(1):7086.","journal-title":"Sci Rep"},{"issue":"11","key":"952_CR39","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/s41590-021-01040-x","volume":"22","author":"SJ Holtkamp","year":"2021","unstructured":"Holtkamp SJ, Ince LM, Barnoud C, Schmitt MT, Sinturel F, Pilorz V, et al. Circadian clocks guide dendritic cells into skin lymphatics. Nat Immunol. 2021;22(11):1375\u201381.","journal-title":"Nat Immunol"},{"issue":"7946","key":"952_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-022-05605-0","volume":"614","author":"C Wang","year":"2023","unstructured":"Wang C, Barnoud C, Cenerenti M, Sun M, Caffa I, Kizil B, et al. Dendritic cells direct circadian anti-tumour immune responses. Nature. 2023;614(7946):136\u201343.","journal-title":"Nature"},{"issue":"4","key":"952_CR41","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1080\/07420529309059712","volume":"10","author":"P Bourin","year":"1993","unstructured":"Bourin P, Mansour I, Doinel C, Rou\u00e9 R, Rouger P, Levi F. Circadian rhythms of circulating NK cells in healthy and human immunodeficiency virus-infected men. Chronobiol Int. 1993;10(4):298\u2013305.","journal-title":"Chronobiol Int"},{"issue":"1","key":"952_CR42","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.mce.2011.06.039","volume":"349","author":"RW Logan","year":"2012","unstructured":"Logan RW, Sarkar DK. Circadian nature of immune function. Mol Cell Endocrinol. 2012;349(1):82\u201390.","journal-title":"Mol Cell Endocrinol"},{"issue":"5","key":"952_CR43","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.bbi.2005.10.002","volume":"20","author":"A Arjona","year":"2006","unstructured":"Arjona A, Sarkar DK. Evidence supporting a circadian control of natural killer cell function. Brain Behav Immun. 2006;20(5):469\u201376.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"952_CR44","doi-asserted-by":"publisher","first-page":"7618","DOI":"10.4049\/jimmunol.174.12.7618","volume":"174","author":"A Arjona","year":"2005","unstructured":"Arjona A, Sarkar DK. Circadian oscillations of clock genes, cytolytic factors, and cytokines in rat NK cells. J Immunol. 2005;174(12):7618\u201324.","journal-title":"J Immunol"},{"issue":"21","key":"952_CR45","doi-asserted-by":"publisher","first-page":"8447","DOI":"10.1158\/0008-5472.CAN-09-0551","volume":"69","author":"H Taniguchi","year":"2009","unstructured":"Taniguchi H, Fern\u00e1ndez AF, Seti\u00e9n F, Ropero S, Ballestar E, Villanueva A, et al. Epigenetic inactivation of the circadian clock gene BMAL1 in hematologic malignancies. Cancer Res. 2009;69(21):8447\u201354.","journal-title":"Cancer Res"},{"issue":"5","key":"952_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00432-024-05753-y","volume":"150","author":"H Zheng","year":"2024","unstructured":"Zheng H, Wu T, Lin Z, Wang D, Zhang J, Zeng T, et al. Targeting BMAL1 reverses drug resistance of acute myeloid leukemia cells and promotes ferroptosis through HMGB1-GPX4 signaling pathway. J Cancer Res Clin Oncol. 2024;150(5):231.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"8","key":"952_CR47","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1111\/cas.15875","volume":"114","author":"D Wang","year":"2023","unstructured":"Wang D, Wang F, Zhang H, Chen P, Yang M. Circadian clock protein Bmal1 accelerates acute myeloid leukemia by inhibiting ferroptosis through the EBF3\/ALOX15 axis. Cancer Sci. 2023;114(8):3446\u201360.","journal-title":"Cancer Sci"},{"issue":"4","key":"952_CR48","doi-asserted-by":"publisher","first-page":"112054","DOI":"10.1016\/j.isci.2025.112054","volume":"28","author":"H Zheng","year":"2025","unstructured":"Zheng H, Lin Z, Wang D, Zhang J, Zeng T, Shen J, et al. BMAL1-depletion remodels ceramide metabolism to regulate ferroptosis and sorafenib chemosensitivity in acute myeloid leukemia. iScience. 2025;28(4):112054.","journal-title":"iScience"},{"issue":"12","key":"952_CR49","first-page":"6615","volume":"35","author":"MY Yang","year":"2015","unstructured":"Yang MY, Lin PM, Hsiao HH, Hsu JF, Lin HY, Hsu CM, et al. Up-regulation of PER3 Expression Is Correlated with Better Clinical Outcome in Acute Leukemia. Anticancer Res. 2015;35(12):6615\u201322.","journal-title":"Anticancer Res"},{"issue":"2","key":"952_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cell.2016.03.015","volume":"165","author":"RV Puram","year":"2016","unstructured":"Puram RV, Kowalczyk MS, de Boer CG, Schneider RK, Miller PG, McConkey M, et al. Core Circadian Clock Genes Regulate Leukemia Stem Cells in AML. Cell. 2016;165(2):303\u201316.","journal-title":"Cell"},{"issue":"2","key":"952_CR51","doi-asserted-by":"publisher","first-page":"e6949","DOI":"10.1002\/cam4.6949","volume":"13","author":"M Rodriguez","year":"2024","unstructured":"Rodriguez M, Fekry B, Murphy B, Figueroa M, Cheng T, Raber M, et al. Feasible diet and circadian interventions reduce in vivo progression of FLT3-ITD-positive acute myeloid leukemia. Cancer Med. 2024;13(2):e6949.","journal-title":"Cancer Med"},{"issue":"1","key":"952_CR52","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13046-023-02799-7","volume":"42","author":"E Murgo","year":"2023","unstructured":"Murgo E, De Santis E, Sansico F, Melocchi V, Colangelo T, Padovano C, et al. The circadian clock circuitry modulates leukemia initiating cell activity in T-cell acute lymphoblastic leukemia. J Exp Clin Cancer Res. 2023;42(1):218.","journal-title":"J Exp Clin Cancer Res"},{"issue":"6","key":"952_CR53","doi-asserted-by":"publisher","first-page":"zsz320","DOI":"10.1093\/sleep\/zsz320","volume":"43","author":"LMH Steur","year":"2020","unstructured":"Steur LMH, Kaspers GJL, Van Someren EJW, Van Eijkelenburg NKA, Van der Sluis IM, Dors N, et al. Sleep-wake rhythm disruption is associated with cancer-related fatigue in pediatric acute lymphoblastic leukemia. Sleep. 2020;43(6):zsz320.","journal-title":"Sleep"},{"issue":"11","key":"952_CR54","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1002\/pbc.25147","volume":"61","author":"VE Rogers","year":"2014","unstructured":"Rogers VE, Zhu S, Ancoli-Israel S, Hinds PS. Impairment in circadian activity rhythms occurs during dexamethasone therapy in children with leukemia. Pediatr Blood Cancer. 2014;61(11):1986\u201391.","journal-title":"Pediatr Blood Cancer"},{"issue":"2","key":"952_CR55","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1177\/0748730410395527","volume":"26","author":"MY Yang","year":"2011","unstructured":"Yang MY, Yang WC, Lin PM, Hsu JF, Hsiao HH, Liu YC, et al. Altered expression of circadian clock genes in human chronic myeloid leukemia. J Biol Rhythms. 2011;26(2):136\u201348.","journal-title":"J Biol Rhythms"},{"issue":"6","key":"952_CR56","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3892\/etm.2020.9276","volume":"20","author":"N Wang","year":"2020","unstructured":"Wang N, Mi M, Wei X, Sun C. Circadian clock gene Period2 suppresses human chronic myeloid leukemia cell proliferation. Exp Ther Med. 2020;20(6):147.","journal-title":"Exp Ther Med"},{"issue":"3","key":"952_CR57","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12253-009-9227-0","volume":"16","author":"CM Sun","year":"2010","unstructured":"Sun CM, Huang SF, Zeng JM, Liu DB, Xiao Q, Tian WJ, et al. Per2 inhibits k562 leukemia cell growth in vitro and in vivo through cell cycle arrest and apoptosis induction. Pathol Oncol Res. 2010;16(3):403\u201311.","journal-title":"Pathol Oncol Res"},{"issue":"12","key":"952_CR58","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/j.1349-7006.2006.00331.x","volume":"97","author":"MY Yang","year":"2006","unstructured":"Yang MY, Chang JG, Lin PM, Tang KP, Chen YH, Lin HY, et al. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci. 2006;97(12):1298\u2013307.","journal-title":"Cancer Sci"},{"key":"952_CR59","doi-asserted-by":"publisher","first-page":"3","DOI":"10.5334\/jcr.147","volume":"15","author":"S Rahman","year":"2017","unstructured":"Rahman S, Al-Hallaj AS, Nedhi A, Gmati G, Ahmed K, Jama HA, et al. Differential Expression of Circadian Genes in Leukemia and a Possible Role for Sirt1 in Restoring the Circadian Clock in Chronic Myeloid Leukemia. J Circadian Rhythms. 2017;15:3.","journal-title":"J Circadian Rhythms"},{"issue":"1","key":"952_CR60","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11033-013-2841-7","volume":"41","author":"S Rana","year":"2014","unstructured":"Rana S, Munawar M, Shahid A, Malik M, Ullah H, Fatima W, et al. Deregulated expression of circadian clock and clock-controlled cell cycle genes in chronic lymphocytic leukemia. Mol Biol Rep. 2014;41(1):95\u2013103.","journal-title":"Mol Biol Rep"},{"issue":"3","key":"952_CR61","doi-asserted-by":"publisher","first-page":"e34347","DOI":"10.1371\/journal.pone.0034347","volume":"7","author":"M Hanoun","year":"2012","unstructured":"Hanoun M, Eisele L, Suzuki M, Greally JM, H\u00fcttmann A, Aydin S, et al. Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia. PLoS ONE. 2012;7(3):e34347.","journal-title":"PLoS ONE"},{"issue":"4","key":"952_CR62","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1600-0609.2009.01287.x","volume":"83","author":"L Eisele","year":"2009","unstructured":"Eisele L, Prinz R, Klein-Hitpass L, N\u00fcckel H, Lowinski K, Thomale J, et al. Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia. Eur J Haematol. 2009;83(4):320\u20137.","journal-title":"Eur J Haematol"},{"issue":"9","key":"952_CR63","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1002\/ijc.30272","volume":"139","author":"L Costas","year":"2016","unstructured":"Costas L, Benavente Y, Olmedo-Requena R, Casabonne D, Robles C, Gonzalez-Barca EM, et al. Night shift work and chronic lymphocytic leukemia in the MCC-Spain case-control study. Int J Cancer. 2016;139(9):1994\u20132000.","journal-title":"Int J Cancer"},{"issue":"1","key":"952_CR64","doi-asserted-by":"publisher","first-page":"11474","DOI":"10.1038\/s41598-018-29847-z","volume":"8","author":"M Abreu","year":"2018","unstructured":"Abreu M, Basti A, Genov N, Mazzoccoli G, Rel\u00f3gio A. The reciprocal interplay between TNF\u03b1 and the circadian clock impacts on cell proliferation and migration in Hodgkin lymphoma cells. Sci Rep. 2018;8(1):11474.","journal-title":"Sci Rep"},{"issue":"1","key":"952_CR65","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41556-017-0006-y","volume":"20","author":"Y Bu","year":"2018","unstructured":"Bu Y, Yoshida A, Chitnis N, Altman BJ, Tameire F, Oran A, et al. A PERK-miR-211 axis suppresses circadian regulators and protein synthesis to promote cancer cell survival. Nat Cell Biol. 2018;20(1):104\u201315.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"952_CR66","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/CBM-150511","volume":"15","author":"MA Guti\u00e9rrez-Monreal","year":"2015","unstructured":"Guti\u00e9rrez-Monreal MA, Villela L, Baltazar S, Perfecto-Avalos Y, Cardineau GA, Scott SP. A PER3 polymorphism is associated with better overall survival in diffuse large B-cell lymphoma in Mexican population. Cancer Biomark. 2015;15(5):699\u2013705.","journal-title":"Cancer Biomark"},{"issue":"8","key":"952_CR67","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.3109\/10428194.2012.658792","volume":"53","author":"NH Thoennissen","year":"2012","unstructured":"Thoennissen NH, Thoennissen GB, Abbassi S, Nabavi-Nouis S, Sauer T, Doan NB, et al. Transcription factor CCAAT\/enhancer-binding protein alpha and critical circadian clock downstream target gene PER2 are highly deregulated in diffuse large B-cell lymphoma. Leuk Lymphoma. 2012;53(8):1577\u201385.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"952_CR68","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.1158\/0008-5472.CAN-08-4572","volume":"69","author":"AE Hoffman","year":"2009","unstructured":"Hoffman AE, Zheng T, Stevens RG, Ba Y, Zhang Y, Leaderer D, et al. Clock-cancer connection in non-Hodgkin\u2019s lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res. 2009;69(8):3605\u201313.","journal-title":"Cancer Res"},{"issue":"9","key":"952_CR69","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1002\/ijc.23566","volume":"123","author":"TA Lahti","year":"2008","unstructured":"Lahti TA, Partonen T, Kyyr\u00f6nen P, Kauppinen T, Pukkala E. Night-time work predisposes to non-Hodgkin lymphoma. Int J Cancer. 2008;123(9):2148\u201351.","journal-title":"Int J Cancer"},{"issue":"3","key":"952_CR70","doi-asserted-by":"publisher","first-page":"110846","DOI":"10.1016\/j.ygeno.2024.110846","volume":"116","author":"X Yan","year":"2024","unstructured":"Yan X, Xu K, Xu Z, Shi C, Lai B, Wu H, et al. GLYR1 transcriptionally regulates PER3 expression to promote the proliferation and migration of multiple myeloma. Genomics. 2024;116(3):110846.","journal-title":"Genomics"},{"issue":"6","key":"952_CR71","doi-asserted-by":"publisher","first-page":"464","DOI":"10.14740\/wjon1681","volume":"14","author":"R Wang","year":"2023","unstructured":"Wang R, Liu SL, Guo QQ, Shi XH, Ma MM. Circadian Clock REV-ERBs Agonist SR9009 Induces Synergistic Antitumor Activity in Multiple Myeloma by Suppressing Glucose-Regulated Protein 78-Dependent Autophagy and Lipogenesis. World J Oncol. 2023;14(6):464\u201375.","journal-title":"World J Oncol"},{"issue":"9","key":"952_CR72","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1002\/cam4.1690","volume":"7","author":"HB Valdimarsdottir","year":"2018","unstructured":"Valdimarsdottir HB, Figueiro MG, Holden W, Lutgendorf S, Wu LM, Ancoli-Israel S, et al. Programmed environmental illumination during autologous stem cell transplantation hospitalization for the treatment of multiple myeloma reduces severity of depression: A preliminary randomized controlled trial. Cancer Med. 2018;7(9):4345\u201353.","journal-title":"Cancer Med"},{"issue":"1","key":"952_CR73","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/(SICI)1096-8652(199609)53:1<40::AID-AJH9>3.0.CO;2-5","volume":"53","author":"P Pasqualetti","year":"1996","unstructured":"Pasqualetti P, Collacciani A, Casale R. Circadian rhythm of serum erythropoietin in multiple myeloma. Am J Hematol. 1996;53(1):40\u20132.","journal-title":"Am J Hematol"},{"issue":"6","key":"952_CR74","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/0024-3205(91)90585-Y","volume":"49","author":"P Pasqualetti","year":"1991","unstructured":"Pasqualetti P, Casale R, Colantonio D, Collacciani A, Natali G. Diurnal variations of serum beta 2-microglobulin in multiple myeloma. Life Sci. 1991;49(6):435\u20138.","journal-title":"Life Sci"},{"issue":"5","key":"952_CR75","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S1470-2045(00)00326-0","volume":"2","author":"F L\u00e9vi","year":"2001","unstructured":"L\u00e9vi F. Circadian chronotherapy for human cancers. Lancet Oncol. 2001;2(5):307\u201315.","journal-title":"Lancet Oncol"},{"issue":"3","key":"952_CR76","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1016\/S1470-2045(21)00639-2","volume":"23","author":"MI Printezi","year":"2022","unstructured":"Printezi MI, Kilgallen AB, Bond MJG, \u0160tibler U, Putker M, Teske AJ, et al. Toxicity and efficacy of chronomodulated chemotherapy: a systematic review. Lancet Oncol. 2022;23(3):e129\u201343.","journal-title":"Lancet Oncol"},{"issue":"4","key":"952_CR77","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1002\/1097-0142(19920215)69:4<893::AID-CNCR2820690410>3.0.CO;2-X","volume":"69","author":"F L\u00e9vi","year":"1992","unstructured":"L\u00e9vi F, Misset JL, Brienza S, Adam R, Metzger G, Itzakhi M, et al. A chronopharmacologic phase II clinical trial with 5-fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer. Cancer. 1992;69(4):893\u2013900.","journal-title":"Cancer"},{"issue":"12","key":"952_CR78","first-page":"2532","volume":"85","author":"F L\u00e9vi","year":"1999","unstructured":"L\u00e9vi F, Zidani R, Brienza S, Dogliotti L, Perpoint B, Rotarski M, et al. A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma. Int Organ Cancer Chronotherapy Cancer. 1999;85(12):2532\u201340.","journal-title":"Int Organ Cancer Chronotherapy Cancer"},{"issue":"9079","key":"952_CR79","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0140-6736(97)03358-8","volume":"350","author":"F L\u00e9vi","year":"1997","unstructured":"L\u00e9vi F, Zidani R, Misset JL. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer. International Organization for Cancer Chronotherapy. Lancet. 1997;350(9079):681\u20136.","journal-title":"Lancet"},{"issue":"22","key":"952_CR80","doi-asserted-by":"publisher","first-page":"3562","DOI":"10.1200\/JCO.2006.06.1440","volume":"24","author":"S Giacchetti","year":"2006","unstructured":"Giacchetti S, Bjarnason G, Garufi C, Genet D, Iacobelli S, Tampellini M, et al. Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group. J Clin Oncol. 2006;24(22):3562\u20139.","journal-title":"J Clin Oncol"},{"key":"952_CR81","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.pharmtox.47.120505.105208","volume":"47","author":"F Levi","year":"2007","unstructured":"Levi F, Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu Rev Pharmacol Toxicol. 2007;47:593\u2013628.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"952_CR82","first-page":"509","volume":"17","author":"E Filipski","year":"2006","unstructured":"Filipski E, Li XM, L\u00e9vi F. Disruption of circadian coordination and malignant growth. Cancer Causes Control. 2006;17(4):509\u201314.","journal-title":"Cancer Causes Control"},{"issue":"12","key":"952_CR83","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1093\/annonc\/mds148","volume":"23","author":"S Giacchetti","year":"2012","unstructured":"Giacchetti S, Dugu\u00e9 PA, Innominato PF, Bjarnason GA, Focan C, Garufi C, et al. Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. Ann Oncol. 2012;23(12):3110\u20136.","journal-title":"Ann Oncol"},{"issue":"11","key":"952_CR84","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1158\/0008-5472.CAN-08-4747","volume":"69","author":"PF Innominato","year":"2009","unstructured":"Innominato PF, Focan C, Gorlia T, Moreau T, Garufi C, Waterhouse J, et al. Circadian rhythm in rest and activity: a biological correlate of quality of life and a predictor of survival in patients with metastatic colorectal cancer. Cancer Res. 2009;69(11):4700\u20137.","journal-title":"Cancer Res"},{"issue":"24","key":"952_CR85","doi-asserted-by":"publisher","first-page":"7176","DOI":"10.1158\/0008-5472.CAN-13-1528","volume":"73","author":"XM Li","year":"2013","unstructured":"Li XM, Mohammad-Djafari A, Dumitru M, Dulong S, Filipski E, Siffroi-Fernandez S, et al. A circadian clock transcription model for the personalization of cancer chronotherapy. Cancer Res. 2013;73(24):7176\u201388.","journal-title":"Cancer Res"},{"key":"952_CR86","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev-pharmtox-051920-095416","volume":"64","author":"FA L\u00e9vi","year":"2024","unstructured":"L\u00e9vi FA, Okyar A, Hadadi E, Innominato PF, Ballesta A. Circadian Regulation of Drug Responses: Toward Sex-Specific and Personalized Chronotherapy. Annu Rev Pharmacol Toxicol. 2024;64:89\u2013114.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"10","key":"952_CR87","doi-asserted-by":"publisher","first-page":"e013026","DOI":"10.1136\/jitc-2025-013026","volume":"13","author":"S Ismail-Sutton","year":"2025","unstructured":"Ismail-Sutton S, Hughes B, Buchwald ZS, Wreglesworth NI, Dallmann R, Innominato PF. Personalizing chronotherapy of immune checkpoint blockade. J Immunother Cancer. 2025;13(10):e013026.","journal-title":"J Immunother Cancer"},{"issue":"11","key":"952_CR88","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1016\/j.cell.2025.03.022","volume":"188","author":"Y Hou","year":"2025","unstructured":"Hou Y, Wu Y, Cao Y, Hu X, Sun Y, Wang H, et al. Optimizing stem cell infusion timing in the prevention of acute graft-versus-host disease. Cell. 2025;188(11):3030\u2013e4417.","journal-title":"Cell"},{"issue":"1","key":"952_CR89","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-026-68958-4","volume":"17","author":"Y Wu","year":"2026","unstructured":"Wu Y, Hou Y, Wang D, Wang L, Song K, Sun G, et al. Circadian fluctuation of soluble CD26 dictates the impact of the timing of cord blood transplantation on acute graft-versus-host disease. Nat Commun. 2026;17(1):2176.","journal-title":"Nat Commun"},{"issue":"12","key":"952_CR90","doi-asserted-by":"publisher","first-page":"e01337","DOI":"10.1136\/jitc-2025-013372","volume":"13","author":"C Bernardi","year":"2025","unstructured":"Bernardi C, Pradier A, Masouridi-Levrat S, Morin S, Mamez AC, Giannotti F, et al. Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes: a validation cohort study. J Immunother Cancer. 2025;13(12):e01337.","journal-title":"J Immunother Cancer"},{"issue":"3","key":"952_CR91","doi-asserted-by":"publisher","first-page":"e201159","DOI":"10.1172\/jci.insight.201159","volume":"11","author":"PG Lyons","year":"2026","unstructured":"Lyons PG, Gill E, Kumar P, Beasley M, Park-Egan B, Lokhandwala ZA, et al. Diurnal rhythm in chimeric antigen receptor T cell effectiveness in an observational study of 715 patients. JCI Insight. 2026;11(3):e201159.","journal-title":"JCI Insight"},{"issue":"12","key":"952_CR92","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1182\/blood.2025031476","volume":"147","author":"D Luan","year":"2026","unstructured":"Luan D, Ben Valid O, Beyar-Katz O, Tix T, Accav NG, Alhomoud M, et al. Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma. Blood. 2026;147(12):1315\u201322.","journal-title":"Blood"},{"issue":"19","key":"952_CR93","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1182\/blood.2025032307","volume":"147","author":"MR Dowling","year":"2026","unstructured":"Dowling MR, Cliff ERS, Jeffrey A, Cashion C, Boyle S, Li J, et al. Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma. Blood. 2026;147(19):2272\u20137.","journal-title":"Blood"},{"issue":"10","key":"952_CR94","doi-asserted-by":"publisher","first-page":"E386","DOI":"10.1002\/ajh.26293","volume":"96","author":"A Khurana","year":"2021","unstructured":"Khurana A, Hathcock M, Habermann TM, Al Saleh AS, Gandhi S, Truong T, et al. Lines of therapy before autologous stem cell transplant and CAR-T affect outcomes in aggressive Non-Hodgkin\u2019s lymphoma. Am J Hematol. 2021;96(10):E386\u20139.","journal-title":"Am J Hematol"},{"issue":"10","key":"952_CR95","first-page":"793","volume":"44","author":"MY Du","year":"2023","unstructured":"Du MY, Zhang YQ, Liao DY, Xie W, Xiong W, Mei H, et al. [Long-term follow-up of humanized and murine CD19 CAR-T-cell therapy for B-cell acute lymphoblastic leukemia]. Zhonghua Xue Ye Xue Za Zhi. 2023;44(10):793\u20139.","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"issue":"12","key":"952_CR96","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.3390\/vaccines12121348","volume":"12","author":"ST Tsao","year":"2024","unstructured":"Tsao ST, Gu M, Xiong Q, Deng Y, Deng T, Fu C, et al. Rapidly Manufactured CAR-T with Conserved Cell Stemness and Distinctive Cytokine-Secreting Profile Shows Improved Anti-Tumor Efficacy. Vaccines (Basel). 2024;12(12):1348.","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"952_CR97","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41591-022-01998-7","volume":"28","author":"N Saini","year":"2022","unstructured":"Saini N, Neelapu SS. CAR T(r)(e)(g) cells: prime suspects in therapeutic resistance. Nat Med. 2022;28(9):1755\u20136.","journal-title":"Nat Med"},{"issue":"11","key":"952_CR98","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1016\/j.cell.2024.04.015","volume":"187","author":"C Wang","year":"2024","unstructured":"Wang C, Zeng Q, G\u00fcl ZM, Wang S, Pick R, Cheng P, et al. Circadian tumor infiltration and function of CD8(+) T cells dictate immunotherapy efficacy. Cell. 2024;187(11):2690\u2013e70217.","journal-title":"Cell"},{"issue":"8","key":"952_CR99","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.trecan.2019.07.002","volume":"5","author":"G Sulli","year":"2019","unstructured":"Sulli G, Lam MTY, Panda S. Interplay between Circadian Clock and Cancer: New Frontiers for Cancer Treatment. Trends Cancer. 2019;5(8):475\u201394.","journal-title":"Trends Cancer"},{"issue":"3","key":"952_CR100","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/nri3386","volume":"13","author":"C Scheiermann","year":"2013","unstructured":"Scheiermann C, Kunisaki Y, Frenette PS. Circadian control of the immune system. Nat Rev Immunol. 2013;13(3):190\u20138.","journal-title":"Nat Rev Immunol"},{"issue":"6530","key":"952_CR101","doi-asserted-by":"publisher","first-page":"eabd0951","DOI":"10.1126\/science.abd0951","volume":"371","author":"KB Koronowski","year":"2021","unstructured":"Koronowski KB, Sassone-Corsi P. Communicating clocks shape circadian homeostasis. Science. 2021;371(6530):eabd0951.","journal-title":"Science"},{"issue":"2","key":"952_CR102","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1192\/bja.2020.47","volume":"27","author":"J Scott","year":"2021","unstructured":"Scott J, Langsrud K, Goulding IR, Kallestad H. Let there be blue-depleted light: in-patient dark therapy, circadian rhythms and length of stay. BJPsych Adv. 2021;27(2):73\u201384.","journal-title":"BJPsych Adv"},{"issue":"2","key":"952_CR103","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.cmet.2019.06.019","volume":"30","author":"CR Cederroth","year":"2019","unstructured":"Cederroth CR, Albrecht U, Bass J, Brown SA, Dyhrfjeld-Johnsen J, Gachon F, et al. Medicine in the Fourth Dimension. Cell Metab. 2019;30(2):238\u201350.","journal-title":"Cell Metab"},{"issue":"9","key":"952_CR104","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.tips.2018.07.003","volume":"39","author":"G Sulli","year":"2018","unstructured":"Sulli G, Manoogian ENC, Taub PR, Panda S. Training the Circadian Clock, Clocking the Drugs, and Drugging the Clock to Prevent, Manage, and Treat Chronic Diseases. Trends Pharmacol Sci. 2018;39(9):812\u201327.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"952_CR105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pnpbp.2006.06.020","volume":"31","author":"SR Pandi-Perumal","year":"2007","unstructured":"Pandi-Perumal SR, Smits M, Spence W, Srinivasan V, Cardinali DP, Lowe AD, et al. Dim light melatonin onset (DLMO): a tool for the analysis of circadian phase in human sleep and chronobiological disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(1):1\u201311.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"10","key":"952_CR106","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.psyneuen.2009.06.011","volume":"34","author":"EK Adam","year":"2009","unstructured":"Adam EK, Kumari M. Assessing salivary cortisol in large-scale, epidemiological research. Psychoneuroendocrinology. 2009;34(10):1423\u201336.","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"952_CR107","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/sleep\/26.3.342","volume":"26","author":"S Ancoli-Israel","year":"2003","unstructured":"Ancoli-Israel S, Cole R, Alessi C, Chambers M, Moorcroft W, Pollak CP. The role of actigraphy in the study of sleep and circadian rhythms. Sleep. 2003;26(3):342\u201392.","journal-title":"Sleep"},{"issue":"1","key":"952_CR108","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13073-017-0406-4","volume":"9","author":"JJ Hughey","year":"2017","unstructured":"Hughey JJ. Machine learning identifies a compact gene set for monitoring the circadian clock in human blood. Genome Med. 2017;9(1):19.","journal-title":"Genome Med"},{"issue":"1","key":"952_CR109","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1177\/0748730402239679","volume":"18","author":"T Roenneberg","year":"2003","unstructured":"Roenneberg T, Wirz-Justice A, Merrow M. Life between clocks: daily temporal patterns of human chronotypes. J Biol Rhythms. 2003;18(1):80\u201390.","journal-title":"J Biol Rhythms"},{"issue":"6","key":"952_CR110","first-page":"889","volume":"38","author":"HJ Burgess","year":"2015","unstructured":"Burgess HJ, Wyatt JK, Park M, Fogg LF. Home Circadian Phase Assessments with Measures of Compliance Yield Accurate Dim Light Melatonin Onsets. Sleep. 2015;38(6):889\u201397.","journal-title":"Sleep"},{"issue":"5","key":"952_CR111","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1210\/jc.2008-2380","volume":"94","author":"M Debono","year":"2009","unstructured":"Debono M, Ghobadi C, Rostami-Hodjegan A, Huatan H, Campbell MJ, Newell-Price J, et al. Modified-release hydrocortisone to provide circadian cortisol profiles. J Clin Endocrinol Metab. 2009;94(5):1548\u201354.","journal-title":"J Clin Endocrinol Metab"},{"issue":"7","key":"952_CR112","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.5664\/jcsm.7230","volume":"14","author":"MT Smith","year":"2018","unstructured":"Smith MT, McCrae CS, Cheung J, Martin JL, Harrod CG, Heald JL, et al. Use of Actigraphy for the Evaluation of Sleep Disorders and Circadian Rhythm Sleep-Wake Disorders: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2018;14(7):1231\u20137.","journal-title":"J Clin Sleep Med"},{"issue":"39","key":"952_CR113","doi-asserted-by":"publisher","first-page":"E9247","DOI":"10.1073\/pnas.1800314115","volume":"115","author":"R Braun","year":"2018","unstructured":"Braun R, Kath WL, Iwanaszko M, Kula-Eversole E, Abbott SM, Reid KJ, et al. Universal method for robust detection of circadian state from gene expression. Proc Natl Acad Sci U S A. 2018;115(39):E9247\u201356.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"952_CR114","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.smrv.2007.07.005","volume":"11","author":"T Roenneberg","year":"2007","unstructured":"Roenneberg T, Kuehnle T, Juda M, Kantermann T, Allebrandt K, Gordijn M, et al. Epidemiology of the human circadian clock. Sleep Med Rev. 2007;11(6):429\u201338.","journal-title":"Sleep Med Rev"}],"container-title":["Biomarker Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40364-026-00952-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40364-026-00952-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:02:13Z","timestamp":1783609333000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40364-026-00952-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":114,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1186\/s40364-026-00952-w","relation":{},"ISSN":["2050-7771"],"issn-type":[{"value":"2050-7771","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"9 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This review is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors; it does not require the approval of the independent ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}